Ligand Pharmaceuticals | LGND - أسهم رأس المال العادية





أسهم رأس المال العادية تغيير تاريخ
Agenus USD 35.32M 2.51M 2025-12
Amgen USD 540M 1000K 2026-03
Anika Therapeutics USD 13.89M 532K 2025-12
Arrowhead Research USD 137.39M 1.69M 2025-12
Baxter International USD 516.45M 2.17M 2026-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Eli Lilly USD 943.5M 3.33M 2026-03
Enanta Pharmaceuticals USD 212K 1000 2023-12
Enviri Corporation USD 81.45M 797K 2025-12
Gilead Sciences USD 1.24B 1000K 2026-03
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Glaxosmithkline GBP 4.05B 20.6M 2026-03
Heron Therapeutics USD 188.31M 4.99M 2025-12
Insmed USD 216.52M 2.27M 2026-03
Intrexon USD 0 0 2024-06
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
MacroGenics USD 63.56M 241K 2026-03
Merck USD 2.47B 12.72M 2025-12
Pacira USD 39.31M 1.81M 2026-03
Pfizer USD 5.7B 13M 2026-03
Rigel Pharmaceuticals USD 17K 158K 2024-06
Veracyte USD 79.79M 743K 2026-03